• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆 E-选择素水平与镰状细胞病视网膜病变有关。

Plasma levels of E-selectin are associated with retinopathy in sickle cell disease.

机构信息

Centre de référence des syndromes drépanocytaires majeurs, thalassémies et autres pathologies rare du globule rouge et de l'érythropoïèse, Assistance Publique des Hôpitaux de Marseille, Marseille, France.

Département de médecine interne, Hôpital de la Timone, Assistance Publique des Hôpitaux de Marseille, Marseille, France.

出版信息

Eur J Haematol. 2023 Mar;110(3):271-279. doi: 10.1111/ejh.13902. Epub 2022 Nov 30.

DOI:10.1111/ejh.13902
PMID:36409296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10100354/
Abstract

BACKGROUND

The vascular endothelium is markedly disrupted in sickle cell disease (SCD) and is the converging cascade of the complex pathophysiologic processes linked to sickle cell vasculopathy. Circulating endothelial activation and/or apoptotic markers may reflect this endothelial activation/damage that contributes to the pathophysiology of the SCD vascular complications.

METHODS

Plasmatic levels of circulating endothelial cells (CECs), E-selectin, progenitor's endothelial cells (EPCs), and circulating extracellular vesicles (EVs) were evaluated in 50 SCD patients, 16 with vasculopathy. The association between these markers and the occurrence of disease-related microvascular injuries of the eye (retinopathy), kidney (nephropathy), and skin (chronic active ulcers) was explored.

RESULTS

Among the endothelial activation markers studied, only higher plasma levels of E-selectin were found in SCD patients with vasculopathy (p = .015). Increased E-selectin levels were associated with retinopathy (p < .001) but not with nephropathy or leg ulcers. All patients, at steady state, with or without vasculopathy, did not display a high count of CEC and EPC, markers of endothelial injury and repair. We did not show any significant differences in EVs levels between vasculopathy and not vasculopathy SCD patients.

CONCLUSIONS

Further studies will be required to determine whether the E-selectin could be used as an early biomarker of retinopathy sickle cell development.

摘要

背景

镰状细胞病 (SCD) 患者的血管内皮明显受损,是与镰状细胞血管病相关的复杂病理生理过程的汇聚级联。循环内皮细胞激活和/或凋亡标志物可能反映了这种内皮激活/损伤,有助于 SCD 血管并发症的病理生理。

方法

评估了 50 名 SCD 患者(16 名有血管病)的循环内皮细胞 (CEC)、E-选择素、祖内皮细胞 (EPC) 和循环细胞外囊泡 (EV) 的血浆水平。探讨了这些标志物与眼部(视网膜病变)、肾脏(肾病)和皮肤(慢性活动性溃疡)疾病相关微血管损伤的发生之间的关系。

结果

在所研究的内皮激活标志物中,仅发现血管病 SCD 患者的血浆 E-选择素水平升高(p=0.015)。E-选择素水平升高与视网膜病变相关(p<0.001),但与肾病或腿部溃疡无关。所有处于稳定状态的患者,无论有无血管病,均未显示出 CEC 和 EPC 的高计数,这些标志物代表了内皮损伤和修复。我们没有显示 EVs 水平在血管病和非血管病 SCD 患者之间有任何显著差异。

结论

需要进一步研究以确定 E-选择素是否可作为镰状细胞视网膜病变发展的早期生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6793/10100354/e32b950020d8/EJH-110-271-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6793/10100354/1c066143c2f1/EJH-110-271-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6793/10100354/e32b950020d8/EJH-110-271-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6793/10100354/1c066143c2f1/EJH-110-271-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6793/10100354/e32b950020d8/EJH-110-271-g002.jpg

相似文献

1
Plasma levels of E-selectin are associated with retinopathy in sickle cell disease.血浆 E-选择素水平与镰状细胞病视网膜病变有关。
Eur J Haematol. 2023 Mar;110(3):271-279. doi: 10.1111/ejh.13902. Epub 2022 Nov 30.
2
Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.沙特和非沙特镰状细胞病单倍型中内皮功能障碍和白细胞活化的标志物
Ann Hematol. 2017 Jan;96(1):141-146. doi: 10.1007/s00277-016-2823-7. Epub 2016 Sep 30.
3
Lectin-like oxidized low-density lipoprotein receptor (LOX-1) in sickle cell disease vasculopathy.镰状细胞病血管病变中的凝集素样氧化型低密度脂蛋白受体(LOX-1)
Blood Cells Mol Dis. 2016 Sep;60:44-8. doi: 10.1016/j.bcmd.2016.06.005. Epub 2016 Jun 25.
4
Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality.镰状细胞病患者体内可溶性内皮源性黏附分子水平与肺动脉高压、器官功能障碍及死亡率相关。
Br J Haematol. 2005 Sep;130(6):943-53. doi: 10.1111/j.1365-2141.2005.05701.x.
5
Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.非洲镰状细胞病的贫血程度、间接溶血指标和血管并发症。
Blood. 2017 Nov 16;130(20):2215-2223. doi: 10.1182/blood-2016-12-755777. Epub 2017 Sep 20.
6
Increased circulating PEDF and low sICAM-1 are associated with sickle cell retinopathy.循环中色素上皮衍生因子(PEDF)水平升高及可溶性细胞间黏附分子-1(sICAM-1)水平降低与镰状细胞视网膜病变相关。
Blood Cells Mol Dis. 2015 Jan;54(1):33-7. doi: 10.1016/j.bcmd.2014.08.003. Epub 2014 Aug 29.
7
Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation.镰状细胞病患者血浆中组织因子和可溶性E选择素水平:与基因型及炎症的关系
Blood Coagul Fibrinolysis. 2005 Apr;16(3):209-14. doi: 10.1097/01.mbc.0000164431.98169.8f.
8
Alterations of circulating endothelial cells after apheresis in patients with sickle cell disease: a potential clue for restoration of pathophysiology.镰状细胞病患者进行血液成分单采术后循环内皮细胞的变化:恢复病理生理学的潜在线索
Transfus Apher Sci. 2010 Dec;43(3):273-279. doi: 10.1016/j.transci.2010.09.015. Epub 2010 Oct 15.
9
The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.增殖性镰状视网膜病变中的血管生成素/Tie-2系统:与血管内皮生长因子、其可溶性受体Flt-1及血管性血友病因子的关系,以及与激光治疗效果的关系。
Br J Ophthalmol. 2005 Jul;89(7):815-9. doi: 10.1136/bjo.2004.058164.
10
Sickle cell disease, vasculopathy, and therapeutics.镰状细胞病、血管病变和治疗学。
Annu Rev Med. 2013;64:451-66. doi: 10.1146/annurev-med-120611-143127. Epub 2012 Nov 26.

引用本文的文献

1
Clinical and laboratory risk factors for sickle cell retinopathy and maculopathy: a scoping review of the current evidence.镰状细胞视网膜病变和黄斑病变的临床及实验室风险因素:当前证据的范围综述
Haematologica. 2025 May 1;110(5):1092-1104. doi: 10.3324/haematol.2024.286420. Epub 2024 Dec 19.
2
Selectins in Biology and Human Disease: Opportunity in E-selectin Antagonism.生物学与人类疾病中的选择素:E-选择素拮抗作用的机遇
Cureus. 2024 Jun 9;16(6):e61996. doi: 10.7759/cureus.61996. eCollection 2024 Jun.
3
Evaluation of peripheral blood inflammatory biomarkers in sickle cell disease with and without retinopathy.

本文引用的文献

1
Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study.镰状细胞贫血患者白蛋白尿的进展:一项多中心、纵向研究。
Blood Adv. 2020 Apr 14;4(7):1501-1511. doi: 10.1182/bloodadvances.2019001378.
2
Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties.镰状细胞病患者在危机期间或服用羟基脲时的血浆微粒会改变血管内皮的炎症特性。
Blood. 2020 Jul 9;136(2):247-256. doi: 10.1182/blood.2020004853.
3
The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
评估伴有和不伴有视网膜病变的镰状细胞病患者外周血炎症生物标志物。
Graefes Arch Clin Exp Ophthalmol. 2024 Dec;262(12):3787-3796. doi: 10.1007/s00417-024-06569-9. Epub 2024 Jul 8.
镰状细胞病中的红细胞-炎症恶性循环。
Front Immunol. 2020 Mar 13;11:454. doi: 10.3389/fimmu.2020.00454. eCollection 2020.
4
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.细胞外囊泡研究的最低限度信息2018(MISEV2018):国际细胞外囊泡协会的立场声明及MISEV2014指南的更新
J Extracell Vesicles. 2018 Nov 23;7(1):1535750. doi: 10.1080/20013078.2018.1535750. eCollection 2018.
5
Therapeutic strategies for sickle cell disease: towards a multi-agent approach.镰状细胞病的治疗策略:迈向多药物联合治疗方法。
Nat Rev Drug Discov. 2019 Feb;18(2):139-158. doi: 10.1038/s41573-018-0003-2.
6
Sickle cell disease.镰状细胞病。
Nat Rev Dis Primers. 2018 Mar 15;4:18010. doi: 10.1038/nrdp.2018.10.
7
Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment.镰状细胞肾病:病理生理学、诊断及治疗的最新进展
Int Urol Nephrol. 2018 Jun;50(6):1075-1083. doi: 10.1007/s11255-018-1803-3. Epub 2018 Jan 30.
8
Endothelial cell-derived microvesicles: potential mediators and biomarkers of pathologic processes.内皮细胞衍生的微小囊泡:病理过程的潜在介质和生物标志物。
Biomark Med. 2018 Feb;12(2):161-175. doi: 10.2217/bmm-2017-0182. Epub 2018 Jan 12.
9
Sickle Cell Disease.镰状细胞病
N Engl J Med. 2017 Apr 20;376(16):1561-1573. doi: 10.1056/NEJMra1510865.
10
Intravascular hemolysis and the pathophysiology of sickle cell disease.血管内溶血与镰状细胞病的病理生理学
J Clin Invest. 2017 Mar 1;127(3):750-760. doi: 10.1172/JCI89741.